-
Camille Jubelin，Javier Munoz-Garcia，Denis Cochonneau，Emilie Moranton，Marie-Francoise Heymann，Dominique Heymann（CNRS；Institut de Cancerologie de l’Ouest；Atlantic Bone Screen；Department of Oncology and Metabolism）.Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma[J].癌症耐药(英文),2022,第1期
-
Laia Cuesta-Casanovas，Jennifer Delgado-Martinez，Josep M.Cornet-Masana，Jose M.Carbo，Lise Clement-Demange，Ruth M.Risueno（Josep Carreras Leukaemia Research Institute（IJC）；Faculty of Biosciences；Faculty of Pharmacy；Leukos Biotech）.Lysosome-mediated chemoresistance in acute myeloid leukemia[J].癌症耐药(英文),2022,第1期
-
Emanuela Grassilli，Maria Grazia Cerrito（Department of Medicine and Surgery）.Emerging actionable targets to treat therapyresistant colorectal cancers[J].癌症耐药(英文),2022,第1期
-
Jeff Rytlewski，Qierra R.Brockman，Rebecca D.Dodd，Mohammed Milhem，Varun Monga（Department of Internal Medicine；Holden Comprehensive Cancer Center）.Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance[J].癌症耐药(英文),2022,第1期
-
Gianluigi De Renzi，Giulia De Marco，Michela De Meo，Eleonora Del Rosso，Paola Gazzaniga，Chiara Nicolazzo（Cancer Liquid Biopsy Unit）.In vitro cultures of circulating tumor cells：a potential tool to unravel drug sensitivity[J].癌症耐药(英文),2022,第1期
-
Vaia Florou，Breelyn A.Wilky（Department of Medicine；Department of Medicine）.Emerging mechanisms of immunotherapy resistance in sarcomas[J].癌症耐药(英文),2022,第1期
-
Bernhard Biersack，Bianca Nitzsche，Michael Hopfner（Organic Chemistry Laboratory；Institute of Physiology）.HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer[J].癌症耐药(英文),2022,第1期
-
Salah-Eddine Cherradi-Lamhamedi，Danh Truong，Joseph A.Ludwig（Department of Sarcoma Medical Oncology）.Understanding sarcoma drug resistance one cell at a time[J].癌症耐药(英文),2022,第1期
-
Jing Wu，Suyao Li，Pengfei Zhang（Department of Medical Oncology）.Tumor-derived exosomes：immune properties and clinical application in lung cancer[J].癌症耐药(英文),2022,第1期
-
Peng Ding，Lu Wen，Fan Tong，Ruiguang Zhang，Yu Huang，Xiaorong Dong（Cancer Center）.Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer[J].癌症耐药(英文),2022,第1期
-
WonSeok William Choi，Julia L.Boland，Jianqing Lin（Division of Hematology/Oncology and Department of Medicine）.ONECUT2 as a key mediator of androgen receptorindependent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer[J].癌症耐药(英文),2022,第1期
-
Alessandro Gozzetti，Sara Ciofini，Anna Sicuranza，Paola Pacelli，Donatella Raspadori，Emanuele Cencini，Dania Tocci，Monica Bocchia（Hematology）.Drug resistance and minimal residual disease in multiple myeloma[J].癌症耐药(英文),2022,第1期
-
Claire Comerford，Siobhan Glavey，Jamie M.O’Sullivan，John Quinn（Irish Centre for Vascular Biology；Department of Haematology；Hermitage Medical Clinic；Department of Pathology；School of Medicine）.Potential mechanisms of resistance to current antithrombotic strategies in Multiple Myeloma[J].癌症耐药(英文),2022,第1期
|